Barry L. MacLean Professor of Molecular Engineering Innovation and Enterprise

University of Chicago

Dr. Hubbell’s research focuses on the development of molecular and materials engineering approaches in immunotherapy. He also researches vaccination in infectious disease and cancer and on an antigen-specific tolerance induction to protein drugs, allergens and autoimmune antigens.